Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
Status:
Active, not recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This is an exploratory Phase 2 trial of BMX-010 in patients with Rosacea which will be
conducted in two parts. Up to 210 subjects with Rosacea will be enrolled.